A huge exit on Israeli biomed: Gilead buys Kite Pharma for $11.9 billion in Cash

  Gilead Sciences agreed on Monday to buy Kite Pharma for $11.9 billion in an all-cash deal. This acquisition is one of the biggest ever of a company whose products have not yet approved for marketing. Gilead More...